TScan Therapeutics Inc (NAS:TCRX)
$ 0.67 -0.059 (-8.11%) Market Cap: 45.45 Mil Enterprise Value: 36.18 Mil PE Ratio: 0 PB Ratio: 0.66 GF Score: 44/100

TScan Therapeutics Inc Annual Shareholders Meeting Transcript

May 20, 2026 / 12:30 PM GMT
Release Date Price: $0.9946 (+3.27%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TCRX.OQ - TScan Therapeutics Inc
TScan Therapeutics Inc Annual Shareholders Meeting
May 20, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and welcome to the 2026 Virtual Annual Meeting of T-SCAN Therapeutics, Inc. Please note that today's meeting is being recorded. Stakeholders may submit questions by following the instructions on the annual meeting interface.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, everyone. My name is Gavin McBess, Chief Executive Officer and a Director of QiScan Therapeutics, and I will be acting as Chairman of the meeting.

The meeting is now called to order.

I've asked Zoran Zavoski, our Chief Legal and Strategy Officer and Secretary, to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot